RT Journal Article
SR Electronic
T1 Mapping malaria by sharing spatial information between incidence and prevalence datasets
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.14.20023069
DO 10.1101/2020.02.14.20023069
A1 Lucas, Tim C.D.
A1 Nandi, Anita K.
A1 Chestnutt, Elisabeth G.
A1 Twohig, Katherine A.
A1 Keddie, Suzanne H.
A1 Collins, Emma L.
A1 Howes, Rosalind E.
A1 Nguyen, Michele
A1 Rumisha, Susan F.
A1 Python, Andre
A1 Arambepola, Rohan
A1 Bertozzi-Villa, Amelia
A1 Hancock, Penelope
A1 Amratia, Punam
A1 Battle, Katherine E.
A1 Cameron, Ewan
A1 Gething, Peter W.
A1 Weiss, Daniel J.
YR 2020
UL http://medrxiv.org/content/early/2020/02/17/2020.02.14.20023069.abstract
AB As malaria incidence decreases and more countries move towards elimination, maps of malaria risk in low prevalence areas are increasingly needed. For low burden areas, disaggregation regression models have been developed to estimate risk at high spatial resolution from routine surveillance reports aggregated by administrative unit polygons. However, in areas with both routine surveillance data and prevalence surveys, models that make use of the spatial information from prevalence point-surveys have great potential. Using case studies in Indonesia, Senegal and Madagascar, we compare two methods for incorporating point-level, spatial information into disaggregation regression models. The first simply fits a Gaussian random field to prevalence point-surveys to create a new covariate. The second is a multi-likelihood model that is fitted jointly to prevalence point-surveys and polygon incidence data. We find that the simple model generally performs better than a baseline disaggregation model while the joint model performance was mixed. More generally, our results demonstrate that combining these types of data improves estimates of malaria incidence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGates FoundationAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is used under various data agreements so cannot be shared. Reproducible code with dummy data is available on request and will be hosted on GitHub soon.